TE
科技回声
首页24小时热榜最新最佳问答展示工作
GitHubTwitter
首页

科技回声

基于 Next.js 构建的科技新闻平台,提供全球科技新闻和讨论内容。

GitHubTwitter

首页

首页最新最佳问答展示工作

资源链接

HackerNews API原版 HackerNewsNext.js

© 2025 科技回声. 版权所有。

Controversy over Approval of Aduhelm for Alzheimer’s

2 点作者 rodary将近 4 年前

1 comment

po将近 4 年前
I have been watching and paying attention to Alzheimer&#x27;s research my entire life and it&#x27;s depressing how obvious it has become that amyloid beta plaques are not the fundamental cause of cognitive decline and treating them should not be the target of therapy... and yet...<p>I know &#x27;big medicine&#x27; is the target of liberal and conservative critics alike, but it really does seem like once the medical community gets their reputations sucked into a bad theory it will take a good 40 years to change direction. I know good science is being done too, I just wish that we hadn&#x27;t started a depth-first search decades ago.<p>There is real promise in the various inflammation-based theories. This drug seems like a big distraction.